COMITO, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 1.232
NA - Nord America 1.113
EU - Europa 821
AF - Africa 105
SA - Sud America 52
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.327
Nazione #
US - Stati Uniti d'America 1.090
SG - Singapore 347
VN - Vietnam 346
CN - Cina 281
IT - Italia 245
GB - Regno Unito 108
SE - Svezia 96
DE - Germania 94
HK - Hong Kong 82
FR - Francia 53
NL - Olanda 51
IN - India 41
CH - Svizzera 40
IE - Irlanda 38
ZA - Sudafrica 35
BR - Brasile 31
CI - Costa d'Avorio 28
RU - Federazione Russa 25
JP - Giappone 19
CA - Canada 18
FI - Finlandia 17
NG - Nigeria 16
AT - Austria 15
KR - Corea 14
TH - Thailandia 13
PH - Filippine 12
SC - Seychelles 11
BD - Bangladesh 10
PK - Pakistan 10
TG - Togo 10
TR - Turchia 10
JO - Giordania 9
AR - Argentina 8
BE - Belgio 8
EC - Ecuador 8
EE - Estonia 7
ID - Indonesia 7
IQ - Iraq 7
UA - Ucraina 7
MX - Messico 5
TW - Taiwan 5
BG - Bulgaria 4
ES - Italia 4
SA - Arabia Saudita 4
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
IR - Iran 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
KG - Kirghizistan 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.327
Città #
Singapore 249
Ashburn 153
Chandler 116
Ho Chi Minh City 77
Hong Kong 75
Hanoi 73
San Jose 72
Southend 71
Bologna 65
Fairfield 64
Santa Clara 49
Woodbridge 45
Beijing 39
Dallas 38
Dublin 38
Houston 34
Bern 33
Hefei 31
Seattle 31
Abidjan 28
Johannesburg 26
Los Angeles 26
Cambridge 25
Princeton 24
Boardman 23
Wilmington 23
Dong Ket 22
Frankfurt am Main 16
Helsinki 16
Lauterbourg 16
Milan 16
Tokyo 16
New York 14
Abeokuta 12
Da Nang 12
Rome 12
Haiphong 11
Seoul 11
Turin 11
Ann Arbor 10
Lomé 10
Redondo Beach 10
Amman 9
Buffalo 9
Council Bluffs 9
Munich 9
Falkenstein 8
London 8
Nanjing 8
Brussels 7
Jinan 7
Shanghai 7
Shenyang 7
Tianjin 7
Vienna 7
Westminster 7
Amsterdam 6
Bangkok 6
Düsseldorf 6
Guangzhou 6
Nanchang 6
Biên Hòa 5
Changsha 5
Florence 5
Neuhofen an der Ybbs 5
Ottawa 5
Quận Bình Thạnh 5
Tongling 5
Toronto 5
Bengaluru 4
Berlin 4
Bến Tre 4
Chicago 4
Fuzhou 4
Jakarta 4
Lahore 4
Medford 4
Naples 4
Olalla 4
Padova 4
Paris 4
Parma 4
Phoenix 4
Poplar 4
Quezon City 4
Redwood City 4
Rotterdam 4
Sofia 4
Verona 4
Wuhan 4
Zhengzhou 4
Ankara 3
Bühl 3
Bắc Ninh 3
Campi Bisenzio 3
Can Tho 3
Chennai 3
Costa Volpino 3
Des Moines 3
Fortaleza 3
Totale 2.037
Nome #
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 229
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 220
Circulating tumor cells in genitourinary tumors 213
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 209
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer 208
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience 199
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 190
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 157
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab 155
Non-coding RNA dysregulation in skin cancers 154
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma 145
Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma 141
Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report 123
Defining high-risk patients: beyond the 8the AJCC melanoma staging system 113
Analysis of basal cell carcinomas' histological subtypes and relative response to vismodegib in six patients diagnosed with Gorlin–Goltz syndrome: A retrospective study 98
null 95
Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence 89
A new classification of upper gastrointestinal toxicity induced by immunotherapy: from endoscopic and pathological insights to clinical management 87
Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: A single-institution experience 82
Cemiplimab-Induced alopecia areata 80
Retreatment with sonidegib in a patient with multiple basal cell carcinomas and multiple comorbidities: a complex real-life scenario 77
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis 71
Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors 70
Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY 63
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study 60
Should Fertility Preservation Be Offered to Young Women with Melanoma Receiving Immune Checkpoint Inhibitors? A SWOT Analysis 41
Adjuvant therapy in renal cell carcinoma 37
Totale 3.406
Categoria #
all - tutte 9.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 15 8 56
2021/2022274 6 6 7 8 17 17 8 17 15 66 54 53
2022/2023453 41 58 14 39 36 42 16 26 86 8 31 56
2023/2024211 21 46 15 26 17 29 11 17 4 11 11 3
2024/2025614 35 66 48 56 65 39 36 34 14 67 56 98
2025/20261.379 128 88 129 98 178 73 135 75 372 103 0 0
Totale 3.406